Effect of oral antihyperglycemic drugs on purine metabolism
Gout and diabetes mellitus are metabolic diseases, the pathogenesis of which is based on an excess of organic molecules in the body, in the first case — uric acid (UA), in the second — glucose. It is assumed that UA can also be involved in the pathogenesis of type 2 diabetes mellitus (T2DM), while i...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2021-11-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/12756 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849327422053285888 |
|---|---|
| author | T. S. Panevin |
| author_facet | T. S. Panevin |
| author_sort | T. S. Panevin |
| collection | DOAJ |
| description | Gout and diabetes mellitus are metabolic diseases, the pathogenesis of which is based on an excess of organic molecules in the body, in the first case — uric acid (UA), in the second — glucose. It is assumed that UA can also be involved in the pathogenesis of type 2 diabetes mellitus (T2DM), while insulin resistance and hyperglycemia affect purine metabolism. Both diseases are associated with an increased risk of cardiovascular events. In addition, chronic microcrystalline inflammation, which is absent in asymptomatic hyperuricemia, but is an obligatory component of gout, is probably an independent factor in T2DM, arterial hypertension, and cardiovascular events. The treatment of both diseases is strategically similar: in gout, the goal is to achieve a normal blood MC level, in T2DM — to normalize glycemia, and the frequent combination of these metabolic diseases requires taking into account the effect of drug therapy on concomitant diseases. Most modern antihyperglycemic drugs can affect purine metabolism, which is confirmed by the results of a number of foreign works. At the same time, the effect of T2DM therapy on purine metabolism and gout has not been adequately covered in the domestic literature, which was the purpose of this review. |
| format | Article |
| id | doaj-art-bfdc2e10a3f64db3b5c3bb819ea5eaec |
| institution | Kabale University |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2021-11-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-bfdc2e10a3f64db3b5c3bb819ea5eaec2025-08-20T03:47:53ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782021-11-0124434234910.14341/DM1275610893Effect of oral antihyperglycemic drugs on purine metabolismT. S. Panevin0V.A. Nasonova Research Institute of Rheumatology; Advisory and Diagnostic center of the General Staff of the Armed Forces of the Russian FederationGout and diabetes mellitus are metabolic diseases, the pathogenesis of which is based on an excess of organic molecules in the body, in the first case — uric acid (UA), in the second — glucose. It is assumed that UA can also be involved in the pathogenesis of type 2 diabetes mellitus (T2DM), while insulin resistance and hyperglycemia affect purine metabolism. Both diseases are associated with an increased risk of cardiovascular events. In addition, chronic microcrystalline inflammation, which is absent in asymptomatic hyperuricemia, but is an obligatory component of gout, is probably an independent factor in T2DM, arterial hypertension, and cardiovascular events. The treatment of both diseases is strategically similar: in gout, the goal is to achieve a normal blood MC level, in T2DM — to normalize glycemia, and the frequent combination of these metabolic diseases requires taking into account the effect of drug therapy on concomitant diseases. Most modern antihyperglycemic drugs can affect purine metabolism, which is confirmed by the results of a number of foreign works. At the same time, the effect of T2DM therapy on purine metabolism and gout has not been adequately covered in the domestic literature, which was the purpose of this review.https://www.dia-endojournals.ru/jour/article/view/12756type 2 diabetes mellitusgouthyperuricemiauric acid |
| spellingShingle | T. S. Panevin Effect of oral antihyperglycemic drugs on purine metabolism Сахарный диабет type 2 diabetes mellitus gout hyperuricemia uric acid |
| title | Effect of oral antihyperglycemic drugs on purine metabolism |
| title_full | Effect of oral antihyperglycemic drugs on purine metabolism |
| title_fullStr | Effect of oral antihyperglycemic drugs on purine metabolism |
| title_full_unstemmed | Effect of oral antihyperglycemic drugs on purine metabolism |
| title_short | Effect of oral antihyperglycemic drugs on purine metabolism |
| title_sort | effect of oral antihyperglycemic drugs on purine metabolism |
| topic | type 2 diabetes mellitus gout hyperuricemia uric acid |
| url | https://www.dia-endojournals.ru/jour/article/view/12756 |
| work_keys_str_mv | AT tspanevin effectoforalantihyperglycemicdrugsonpurinemetabolism |